Search filters

List of works by Hidetsugu Tsubouchi

Phase 2, randomized, double-blind, placebo-controlled, 4-week study to evaluate the safety and efficacy of OPA- 15406 (difamilast), a new topical selective phosphodiesterase type-4 inhibitor, in Japanese pediatric patients aged 2-14 years with atopi

scientific article published on 11 November 2019

Paulina is supported by:

About Paulina

Help